论文信息 - Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease - 字舞流文

Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease

J. Halfvarson | V. Bergqvist | J. Ludvigsson | N. Lamichhane | ·. N. Melas | N-P Ekholm | ·. O. Olén | ·. H. Hjortswang | ·. J. Marsal | ·. C. Eriksson | Sweden. Susanna Jäghult Malmö